Biotage AB (Biotage AB) Price-to-Operating-Cash-Flow : 29.20 (As of Apr. 30, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Price-to-Operating-Cash-Flow?

As of today (2024-04-30), Biotage AB's share price is $14.63. Biotage AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.50. Hence, Biotage AB's Price-to-Operating-Cash-Flow Ratio for today is 29.20.

The historical rank and industry rank for Biotage AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

BITGF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.16 Med: 31.67 Max: 59.99
Current: 31.68

During the past 13 years, Biotage AB's highest Price-to-Operating-Cash-Flow Ratio was 59.99. The lowest was 8.16. And the median was 31.67.

BITGF's Price-to-Operating-Cash-Flow is ranked worse than
69.09% of 440 companies
in the Medical Devices & Instruments industry
Industry Median: 21.565 vs BITGF: 31.68

Biotage AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was $0.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.50.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Biotage AB was 18.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -3.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 12.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 17.90% per year.

During the past 13 years, Biotage AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.90% per year. The lowest was -3.60% per year. And the median was 17.25% per year.

Biotage AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Biotage AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Price-to-Operating-Cash-Flow Chart

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

38.17

32.48

48.59

36.01

34.84

Biotage AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															29.67	34.78	29.18	34.84	34.38

Competitive Comparison of Biotage AB's Price-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, Biotage AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotage AB's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biotage AB's Price-to-Operating-Cash-Flow falls into.

Biotage AB Price-to-Operating-Cash-Flow Calculation

Biotage AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	14.63	/	0.501
	=	29.20

Biotage AB's Share Price of today is $14.63.
Biotage AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.50.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Biotage AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Biotage AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (Biotage AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.